Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03315910 · ClinicalTrials.gov registry record · Phase 4
Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites
A Phase 4 study of Smoking Cessation, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- Phase 4
- Development phase
- 807
- Enrollment target
- 18
- Study locations
NCT03315910 is a Phase 4 study of Smoking Cessation that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 807 participants, above the 470-participant average among 188 other Smoking Cessation trials with a reported enrollment target (72% higher). The trial reports 18 study locations across 12 states.
The verdict
NCT03315910, a Phase 4 study of Smoking Cessation, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 807 participants
- Enrollment target
- 18
- Study locations
Study Summary
This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benefits of lung cancer screening by providing a blue print of best practices for screening sites to deliver tobacco treatment to their patients who are smokers, in a way that does not add burden to screening site staff and increases the chances of patients quitting smoking.
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing (MI)
- DRUG Nicotine Replacement Therapy (NRT)
- DRUG Nicotine Lozenge
- BEHAVIORAL Message Framing
- OTHER saliva sample
Study Locations (18)
New York
- NYU Winthrop Hospital - Mineola
- Memorial Sloan Kettering Cancer Center - New York
- Weill Cornell Medical Center - New York
- Montefiore Medical Center (Data Collection Only) - The Bronx
California
- University of Southern California (Data Collection Only) - Los Angeles
- John Muir Health - Walnut Creek
Illinois
- Rush University Medical Center - Chicago
- Riverside Healthcare - Kankakee
Michigan
- Henry Ford Hospital (Data collection only) - Detroit
- Munson Healthcare - Traverse City
Georgia
- WellStar Health System - La Grange
Indiana
- St. Mary Medical Center, Community Healthcare System - Crown Point
Iowa
- MercyOne Des Moines Medical Center (Data Collection Only) - Des Moines
Maine
- Maine Medical Center Cancer Institute - Scarborough
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 807 participants |
| Start Date | 2017-10-10 |
| Est. Completion | 2026-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03315910
The ClinicalTrials.gov registry entry for NCT03315910 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 807 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 470-participant average among 188 other Smoking Cessation trials with a reported enrollment target (72% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 5 interventions - of which Motivational Interviewing (MI) is the first listed.
NCT03315910 reports 18 study locations spanning 12 distinct geographic areas - top geographies include New York, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT03315910 about?
NCT03315910 is a clinical study titled "Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites". This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benefits of lung cancer s...
What is the current status of trial NCT03315910?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 807 participants. The study started on 2017-10-10. Estimated completion is 2026-10.
What conditions does trial NCT03315910 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT03315910?
The interventions under investigation include: Motivational Interviewing (MI) (BEHAVIORAL), Nicotine Replacement Therapy (NRT) (DRUG), Nicotine Lozenge (DRUG), Message Framing (BEHAVIORAL), saliva sample (OTHER).
Who is sponsoring clinical trial NCT03315910?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03315910 being conducted?
This trial has 18 study locations across California, Georgia, Illinois, Indiana, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
RECRUITING · Phase 4
-
The Options 2 Study
RECRUITING · Phase 4
-
Smoking Cessation Program in the Construction Sector
RECRUITING · Phase 4
-
The Avenues Study: Dual Use Cessation
RECRUITING · Phase 4
-
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
RECRUITING · Phase 4
-
Informing Tobacco Treatment Guidelines for African American Non-Daily Smokers
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.